Release date: 2006-10-17
Australian scientist Chris Jackson has made a breakthrough in the treatment of skin ulcers with the development of artificial skin. This innovative technology has shown promising results, reducing ulcer areas by up to 20% after just four weeks of use. Beyond shrinking the wound, the artificial skin also helps reduce inflammation, redness, and the risk of infection, promoting faster healing. Dr. Kelly, a dermatologist involved in the trial, noted that all patients who used the artificial skin experienced improvements, with some seeing a 20% reduction in wound size after four treatments. The initial phase of the experiment was successful, and the next step is to test the product on a larger population. Skin ulcers are wounds that occur below the dermis or within it, often covered with pus, dead tissue, or scabs. They can leave scars and are commonly caused by infections, injuries, or ruptured tumors. These wounds vary in shape, depth, and progression. Most patients with chronic wounds are elderly, and the condition often affects areas with poor blood circulation, such as the legs and feet. This new development could offer a significant improvement in wound care and recovery for many patients. "Meddy Medical Network"
Tetanus Shot,varicella vaccine, Live,Hepatitis B Injection,Hep B Vaccine
FOSHAN PHARMA CO., LTD. , https://www.forepharm.com